Less Is More: Poxvirus Proteolysis
Two proteinases cleave each of the three major poxvirus core proteins, helping to regulate the assembly of infectious viral particles Dennis E. Hruby and Chelsea M. Byrd B efore progeny virus particles depart an infected cell, each virion needs to contain viral nucleic acid, accessory proteins, and enzymes within an outer shell before the capsid structure is completed to shield the sensitive cargo from the external environment. One mechanism that many viruses use to govern this process is morphogenic proteolysis.
During the late stages of replication, immature virions are assembled, into which all the essential viral components are packaged. Then at the proper time and place, virus-encoded proteinases cleave viral structural proteins, launching a series of structural rearrangements that yield the mature infectious viral particle, whose genome is protected and which is ready to be transported to the next susceptible host. Morphogenic proteolysis is crucial for simple RNA viruses such as poliovirus and HIV, and also appears to play a central role in the assembly of more complex DNA viruses such as the poxviruses.
Poxvirus Replication Is Complex
The assembly of poxviruses, such as vaccinia virus, is a complex, extremely well-regulated process. Approximately 200 viral gene products are expressed in a temporally regulated fashion during the replication cycle, culminating in infectious progeny virions within 10 -12 hours. First, enveloped virions bind to susceptible cells, then penetrate the cytoplasm, losing their outer membrane and liberating the viral core, which contains the viral genome, structural proteins, and the viral transcriptional apparatus, including RNA polymerase, capping enzyme, and polyA polymerase ( Fig. 1 ).
Viral early genes, approximately half the viral genome, are transcribed from the intact viral core. Once those early genes are expressed, the viral core breaks down, liberating the viral genome and expressing a second, or intermediate, set of viral gene products. Their appearance advances the virus into the late stage of its life cycle, during which viral DNA is replicated and late-gene products are expressed in perinuclear cytoplasmic virus-producing complexes. All the essential starting materials for progeny virus particles are assembled into a complex that buds through the intermediate compartment to produce spherical noninfectious particles (IV, immature virus). Each of these particles then undergoes a series of condensations and rearrangements to produce infectious particles (IMV, intracellular mature virus) having the hallmark biconcave core and lateral bodies that are observed by thin-section transmission elec-• During the final stages of replication for many viruses, proteinases cleave structural proteins that rearrange before yielding mature viral particles.
• Three major vaccinia virus core proteins, which are products of the A10L, A3L, and L4R genes and make up about one-third of the dry weight of the virion, each derive from higher molecular weight precursors.
• The vaccinia virus G1L gene product appears to be the first example of a virus-encoded metalloproteinase, while the I7L gene product exhibits sequence homology to several cysteine proteinases; both enzymes appear to be needed for viral core protein processing. tron microscopy. Some of the IV particles acquire two additional membranes from the host trans-Golgi to become triple-wrapped intracellular enveloped virus (IEV), with the outermost envelope being lost by membrane fusion as the particle exits the cell to become cell-associated virus (CEV) or extracellular enveloped virus (EEV). Although the details of this morphogenesis pathway are being investigated, we know that morphogenic proteolysis plays a major role in the pathway, helping to convert IV to fully infective IMV particles.
Cleaving the Building Blocks
Because the sizes of the late-phase major poxvirus proteins do not match those of the major virion structural proteins, investigators long suspected that proteolytic processing occurs during virus assembly. Pulse-chase labeling and peptide mapping procedures subsequently confirmed that the three major VV core proteins (A10L, A3L, and L4R gene products) that make up about onethird of the dry weight of the virion all derive from higher-molecular-weight precursors.
The abundance of these proteins in viral particles enables investigators to purify and subject them to Nterminal microsequencing. This analysis reveals that both A3L and L4R are processed by a single endoproteolytic cleava g e w i t h i n a n amino-terminal proximal site containing the tripeptide AGA. The 66-kDa A3L precursor is cut between residues 61 and 62 to produce a 60-kDa product, while the 28-kDa L4R precursor is cut between residues 32 and 33 to produce a 25-kDa product. In contrast, the A10L precursor, which is more slowly processed in vivo, is cleaved at two sites within the protein, between residues 613 and 615 and between residues 696 and 698.
Although the mature A10L, A3L, and L4R proteins are major virion constituents, none of the liberated small peptides has ever been identified. Not finding them could indicate that they are either degraded or extruded from the virion. However, their small size and acidic nature suggest that they might become complexed with the viral DNA to facilitate genome condensation.
In any case, the major VV core proteins are processed at AG(X) sites. Detailed mutagenesis studies confirm the importance of amino acid residues in the AG(X) site as well as protein characteristics within the excised peptide. Furthermore, these studies demonstrate that the core proteins are expressed as a precursor to be packaged into the virion. If mature proteins lacking the cleaved peptide are expressed from plasmids, they remain cytoplasmic and do not become virion-associated, suggesting correct targeting requires structural or sequence attributes of the precursor proteins.
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motifs within the predicted VV proteome, but processing of only some of those motifs has been experimentally verified (Fig. 2) . Some VV proteins contain AGA motifs that are not processed, including those found in the VV DNA polymerase, which is an early gene product, and in F13L, a major constituent of the outer EEV membrane. From these studies, we surmise that processing is "contextual," meaning that VV proteins containing the AGX motif are processed only if they are late proteins and virion core constituents. If so, the precursor apparently is packaged into the IV particle and cleaved when IV is converted to the IMV particle. Drugs such as rifampicin or temperature-sensitive mutations affecting morphogenesis do not interfere with packaging of the precursor proteins but abrogate morphogenic processing.
A Tale of Two Proteinases
Even after recognizing that these poxvirus core proteins are subject to morphogenic proteolysis, the responsible proteinases remained elusive until recently. Many other viruses encode and express proteinases, making it more likely that vaccinia virus with its large genome would follow suit. Moreover, this virus has a broad host range, but no host proteinases are known to recognize and cleave the AGX motif. However, our efforts to identify vaccinia proteinases by testing extracts of virions or virus-infected cells for either core protein precursors or peptides containing AGX cleavage sites proved unsuccessful.
Bioinformatics provided a more fruitful pathway for identifying two proteinases that could be responsible for processing the poxvirus core proteins (Fig. 3) . One of them, the gene product of the VV G1L open reading frame, appears to encode a metalloproteinase, based on the presence of an inverted HXXEH metal-binding site and conserved downstream ENE motif, similar to one found in the thermolysin subfamily of metalloproteinases. We also know that the 67-kDa G1L protein is expressed late during viral infection and that the gene is highly conserved among the poxviruses. Further, despite little primary sequence homology with other proteins, structural threading models reveal a striking structural resemblance to the yeast mitochondrial processing peptidase (MPP), a known metalloproteinase.
G1L appears to be the first example of a virus-encoded metalloproteinase. All other known viral proteinases belong to the cysteine, serine, or aspartic acid classes of proteinases.
We also identified a second candidate poxvirus proteinase, the product of the VV I7L "late" gene, which is expressed as a 47-kDa protein. Like G1L, the I7L gene sequence is highly conserved among poxviruses. The I7L gene product exhibits sequence homology to several cysteine proteinases, including those expressed by members of two other families of DNA viruses, the adenoviruses and asfarviruses, which includes the African swine fever virus (ASFV). Sequence similarities were highest in the region flanking the putative active site of the I7L enzyme, containing histidine, cysteine, and aspartic acid.
Both Proteinases Appear Necessary for Viral Core Processing
Our bioinformatics-based approach uncovered two poxvirus proteinases, but which is the key player? The answer appears to be both. Because a biochemical approach to studying VV proteolysis continues to be elusive, we instead analyzed infected cells with a temperaturesensitive I7L mutant at the nonpermissive temperature, 40°C. Although all the viral proteins are made, including the viral core protein precursors, processing does not occur and no infectious progeny form. However, when plasmids capable of expressing either I7L or G1L are introduced, I7L proves to be a key enzyme for restoring processing. Subsequently we identified the likely active site residues in I7L, verified that cleavage occurs at the correct site within the AGX motif, and demonstrated that I7L cleaves each of the three major core protein precursors, A3L, A10L, and L4R. Thus, like its adenovirus and ASFV homologs, the I7L gene product appears to be the viral core protein proteinase.
What about G1L? Additional insights into the roles and relationships of the I7L and G1L proteinases emerged through our analysis of conditional-lethal I7L and G1L VV mutants. For instance, if I7L activity is repressed, the VV infection proceeds normally through formation of IV, but without core protein processing and condensation. However, if G1L activity is repressed, IV particles form, core protein precursors cleave, and virion core condensation initiates but is not completed.
These results suggest that both I7L and G1L are needed to complete morphogenic proteolysis (Fig. 4) . We hypothesize that during poxvirus assembly, immature viral particles contain all the VV components necessary to produce an infectious virion, including viral DNA, enzymes, and structural proteins with the core proteins in their precursor form. Virion loading and primary envelopment are somehow signaled to the I7L cysteine proteinase, which then cleaves the major structural proteins and initiates core condensation. At this stage, G1L is activated to complete morphogenic processing and produce mature infectious virions. This proteolytic processing cascade could help to ensure that viral assembly is complete and ordered.
Several key questions remain to be answered regarding poxvirus proteolysis. What is the nature of the active I7L and G1L enzymes? Do they act as monomers or multimers? Do they require cofactors or posttranslational modifications for activity? What are the virion substrates of G1L? Does it act on a distinct subset of the AGX motifs, or does G1L cleave a completely different set of proteins? What signals activate the I7L and G1L enzymes at the correct time and place? Answering these questions will depend on establishing in vitro enzyme assays for both enzymes.
Finally, both the I7L and G1L gene products are highly conserved and appear to be essential for virus replication, suggesting that they are potentially important targets for designing antiviral drugs with which to prevent or treat diseases caused by orthopoxviruses such as smallpox or sylvatic monkeypox.
